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Background: Parasitological confirmation of malaria is now recommended in all febrile patients by the World
Health Organization (WHO) to reduce inappropriate use of anti-malarial drugs. Widespread implementation of rapid
diagnostic tests (RDTs) is regarded as an effective strategy to achieve this goal. However, the quality of diagnosis
provided by RDTs in remote rural dispensaries and health centres is not ideal. Feasible RDT quality control
programmes in these settings are challenging. Collection of information regarding diagnostic events is also very
deficient in low-resource countries.
Methods: A prospective cohort of consecutive patients aged more than one year from both genders, seeking
routine care for febrile episodes at dispensaries located in the Bagamoyo district of Tanzania, were enrolled into the
study after signing an informed consent form. Blood samples were taken for thick blood smear (TBS) microscopic
examination and malaria RDT (SD Bioline Malaria Antigen Pf/Pan™ (SD RDT)). RDT results were interpreted by both
visual interpretation and Deki Reader™ device. Results of visual interpretation were used for case management
purposes. Microscopy was considered the “gold standard test” to assess the sensitivity and specificity of the Deki
Reader interpretation and to compare it to visual interpretation.
Results: In total, 1,346 febrile subjects were included in the final analysis. The SD RDT, when used in conjunction
with the Deki Reader and upon visual interpretation, had sensitivities of 95.3% (95% CI, 90.6-97.7) and 94.7% (95%
CI, 89.8–97.3) respectively, and specificities of 94.6% (95% CI, 93.5–96.1) and 95.6% (95% CI, 94.2–96.6), respectively
to gold standard. There was a high percentage of overall agreement between the two methods of interpretation.
Conclusion: The sensitivity and specificity of the Deki Reader in interpretation of SD RDTs were comparable to
previous reports and showed high agreement to visual interpretation (>98%). The results of the study reflect the
situation in real practice and show good performance characteristics of Deki Reader on interpreting malaria RDTs in
the hands of local laboratory technicians. They also suggest that a system like this could provide great benefits to
the health care system. Further studies to look at ease of use by community health workers, and cost benefit of the
system are warranted.
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Responding to the World Health Organization (WHO)
recommendation that treatment for malaria cases should
be administered only to cases with parasitological con-
firmation either by microscopy or rapid diagnostic tests
(RDTs), many countries in sub-Saharan Africa (SSA)
have adopted the use of malaria RDTs to improve case
management and promote appropriate use of anti-
malarial drugs [1]. The apparent simplicity of malaria
RDT makes them especially attractive for diagnosis at all
levels of health care systems, particularly in remote areas
where health workers have limited supervision and train-
ing. The reliability of malaria RDT results is pivotal to
ensuring the safety of withholding anti-malarial treat-
ment in test-negative patients [2-5].
The possibility of error in diagnosis using RDTs can be
minimized through a careful selection process of RDTs,
as recommended by WHO [6]. Among others, import-
ant steps involved in the process to ensure high quality
of malaria RDT include high diagnostic performance (as
assessed in product testing by WHO and the Foundation
for Innovative New Diagnostics [7]), proper storage con-
ditions of the tests, adequate labelling, clear performance
instructions, continuous on-the-job training (job aids),
and automated interpretation to avoid inter-user vari-
ability. Previous studies have demonstrated improvement
in the performance of health professionals using malaria
RDTs through simple redesign of job aids [8,9].
Large-scale implementation of a diagnostic programme
based on malaria RDTs requires the establishment of a
comprehensive quality assurance (QA) strategy. This task
can be particularly challenging considering that most RDTs
are being used at point-of-care (POC) in health centres and
dispensaries located in remote areas. Current recommenda-
tions by WHO include assessment of the competence of
community health workers to perform RDTs, and to inter-
pret and correctly use the results during supervisory visits,
by direct observation with a standard checklist [10]. How-
ever, research has shown that although QA programmes
based on direct supervision can produce good outcomes,
their sustainability is highly questioned due to the costs
implicated in personnel, transportation and others [11,12].
One way to overcome these additional costs is by
conducting supervisory activities from a remote location,
increasing the efficiency of the system as one supervisor
can conduct QA activities to multiple facilities without the
need of visiting the sites. Remote supervision by means of
photographed HIV and malaria RDTs has been shown to
give good results in preliminary studies [13-15].
Recently, the Fio Corporation (Toronto, Canada)
has developed a solution based on smartphone tech-
nology consisting of a mobile, battery-operated device
(Deki™Reader), with a touch screen interface, that per-
forms automated interpretation of RDTs (universalreader) using proprietary digital image analysis soft-
ware. Information related to the diagnostic event
(demographics, symptoms, etc) is collected through the
user interface, and after the RDT has been interpreted,
the data along with a high-resolution image of the RDT
are transmitted to a server using mobile-phone tech-
nology. At Fio cloud database (airFio™) the data are ag-
gregated, analysed and presented in customized reports
that can be accessed by authorized users in real time
via a secure website portal.
The use of new technologies, such as the one used in the
present study, can help the large-scale implementation of
RDT programmes by minimizing the chance of errors in
diagnosis, providing expedited reporting of all diagnostic
events, including those performed at remote POC loca-
tions, and allowing close monitoring of quality perform-
ance in the field. The objective of the present study was to
assess the clinical diagnostic accuracy of the SD RDT when
interpreted by the Deki Reader device and to compare it to
the visual interpretation of RDTs by experts for detection
of Plasmodium falciparum infections in an outpatient
population in a malaria-endemic area of Tanzania.
Methods
Study design and participants
This was a study conducted in a prospective cohort of
consecutive patients from January to March 2012 at
Bagamoyo district in Tanzania. The district is situated
north of Dar es Salaam and has an estimated population
of 270,000 inhabitants, all of whom are considered to be
at risk to develop malaria.
Recruitment was from three peripheral health care dis-
pensaries (Kiwangwa, Yombo, and Fukayosi) located in
the rural vicinity (approximately 30 km from the town
of Bagamoyo), and from Bagamoyo District Hospital
outpatient clinic in the urban centre of Bagamoyo. Sub-
jects from both genders older than one year who were
seeking routine care for malaria were enrolled into the
study. A patient was enrolled once they were found to
meet inclusion and exclusion criteria and had signed a
study specific informed consent form.
Before the conduct of the trial, the protocol was
reviewed and approved by national (Ref: NIMR/R.8a/Vol.
IX/l244) and institutional (Ref: IHI/IRB/No: 34) ethics
committees and regulatory authority, TFDA (Ref: No:
CEm57/180/04A/54).
Malaria rapid diagnostic tests
The malaria RDT used in the current trial was SD
Bioline Malaria Antigen Pf/Pan (Catalogue No. 05FK60,
Standard Diagnostics Inc, Hagal-Dong, Korea, from now
on referred as “SD RDT”). This is a lateral flow
immunochromatographic test that contains a membrane
strip encased in a flat plastic cassette. The strip is
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P. falciparum HRP2 and one that is pan-specific for
pLDH for detection of other Plasmodium species.
The Deki Reader™
This mobile, rugged, battery-operated device (Fio Corpor-
ation, Toronto, Canada) performs the following functions
(see Figure 1):
1. Automated interpretation of RDTs by means of
image analysis software;
2. Digital data capture, by means of a touch-screen and
a simple user interface software;
3. Transmission in real time using local mobile phone
network of processed RDT image, diagnostic event
data collected, geopositioning of the device, and date
and time stamp to a central database, which is
accessible via internet.
Procedures
Eligible participants were consecutively enrolled in the dis-
pensaries and at the outpatient clinic in Bagamoyo District
Hospital. Inclusion criteria were age over one year, a docu-
mented fever or a history of fever in the previous 48 hours
and consent to participate in the study. No information re-
garding recent self-treatment with anti-malarials was
collected. Clinicians enrolled study participants and col-
lected demographic and clinical information using a struc-
tured form.
After enrolment and physical examination by the study
clinician, blood was collected from a finger prick once (no
follow ups) and about three to four drops were collected in
a heparinized microtube and sent to the reference labora-
tory of Ifakara Health Institute in Bagamoyo for prepar-
ation of thick blood smear (TBS) and a filter paper blood
spot for polymerase chain reaction (PCR) testing, to be
performed as quality control of microscopy. TechniciansFigure 1 Deki ReaderTM device.working at the reference laboratory were blinded to results
of both visual and device interpretation of malaria RDTs
performed at the site. Results of TBS microscopy examin-
ation and PCR (when applicable) were blinded to site tech-
nician who performed RDTs. At each of the study sites, the
study technician collected blood from a finger prick for the
processing of SD RDTs according to manufacturer’s rec-
ommendations. The processing of the RDT was guided by
a job aid displayed on the screen of the Deki Reader device.
The device also assisted technicians at the sites in keeping
track of the incubation time for each RDT processed. Once
the incubation period was completed, the study technician
interpreted the RDT by visual inspection of the strip and
captured the result using the touchscreen of the device.
The study technician then immediately inserted the cas-
sette into the device to perform the automated interpret-
ation of the test. The results of the device’s interpretation
of the RDT were concealed at all times, and were gener-
ated in all cases after the study site technician had entered
results of her/his visual interpretation of RDT test results.
All results of interpretation of RDTs, along with a high-
resolution image of the RDT, and patient data collected
were encrypted and automatically transmitted to a central
cloud database specifically designed for the purpose of
the trial.
Patient management was performed according to rou-
tine local protocols, involving results of RDTs after visual
interpretation by the study technician, and the opinion of
the clinician at the site.
Laboratory analyses
TBS microscopy and PCR tests were performed at Ifakara
Health Institute Reference Laboratory, Bagamoyo by tech-
nicians who were blinded to results of RDT interpretation
by both expert study technicians and the Deki Reader.
At the reference laboratory, blood smears were stained
using 10% Giemsa solution for 30 minutes and examined
under high-power objective. In positive smears, asexual
and sexual parasites were counted against 200 and 500
white blood cells (WBCs), respectively. Parasite density
was obtained by multiplying the parasite counts by 40
for asexual and 16 for sexual parasites (assuming each
μL of blood contained 8,000 WBCs). A smear was de-
clared negative after examining 200 high-power fields.
PCR was performed in all cases of discrepant results
between expert visual interpretation of RDT, device’s in-
terpretation of RDT and expert microscopy results (tie-
breaker); and in a randomly selected subset of negative
and positive samples (quality control of TBS micros-
copy). The PCR technique has high analytical sensitivity,
allowing for qualitative and quantitative demonstration
of parasites in clinical samples.
Molecular analysis involved extraction of parasite
DNA from dried blood spots on filter papers. The DNA
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beta tubulin target gene. DNA was extracted from dried
blood spots by using QIAamp DNA mini kit (Qiagen),
and PCR amplification was performed using Invitrogen
QPCR SuperMix-UDG kit (Invitrogen). Real-time PCR
amplification was done using MxPro3005 QPCR System
(Agilent Technologies Inc, USA); forward (5’-TGA TGT
GCG CAA GTG ATC C-3’) and reverse (5’-TCC TTT
GTG GAC ATT CTT CCT C-3’) primers hybridize to
the pathogen DNA. A probe (5’-TA GCA CAT GCC
GTT AAA TAT CTT CCA TGT CT-3’) is included in
the same reaction mixture. During PCR amplification, if
the DNA of interest was present and amplified, the
probe was cleaved and the reporter dye and quencher
were separated leading to production of fluorescence. At
the end of each PCR cycle, the resulting increase in
fluorescence was detected by qPCR system as fluores-
cence units. As amplification continued, the cycle num-
ber at which detection of DNA products (threshold
cycle value) was reached, and this information together
with the standards (3D7 200,000 p/μl; 20,000 p/μl; 2,000
p/μl; 200 p/μl; 20 p/μl) gave the value of parasitaemia.Statistical analysis
Data were obtained from source documents at each of the
participant sites and compared to information collected
through devices and transmitted to the Fio cloud database.
Data collected were monitored according to FDA regula-
tions and GCP guidelines. There were three outcomes of
interest for the purpose of the analysis in the current trial:
a) visual interpretation of RDT: performed by laboratory
technician at the site following visual inspection of the SD
RDT at the appropriate time. This information was en-
tered by the technician into the device; b) device interpret-
ation of RDT: performed by the device, which was
collected automatically by the device and transmitted to
the database; and, c) microscopy results: performed on
TBS by laboratory technician at reference laboratory and
entered into the dataset manually. For the purpose of the
analysis the result of TBS microscopy was considered the
“gold standard”.
Data collected at the Fio database were compared to data
collected in the internal memory card of each Deki Reader
device to ensure all data points were correctly transmitted
to the cloud database. Data analysis was performed using
JMP Version 8.0.2 and R Version 2.12.1 (SAS Institute Inc,
NC, USA).
The primary analysis was conducted using TBS mi-
croscopy as gold standard to determine diagnostic per-
formance characteristics (sensitivity, specificity, negative
(NPV) and positive (PPV) predictive values, and overall
diagnostic accuracy) of RDT interpretation by the Deki
Reader and by visual interpretation. Correspondent 95%confidence intervals were constructed using the Wilson
score method.
The percentage of agreement in the interpretation of SD
RDT between the device and visual (human eye) done by
the expert laboratory technicians at the sites was calcu-
lated as percentage of negative agreement, percentage of
positive agreement and overall percentage of agreement.
Two-sided 95% confidence intervals were constructed
using the Wilson score method.
Sample size estimate
Although the RDT used in the present study is able to
detect malaria infections caused by all Plasmodium spe-
cies (categorized as “P.f” and “Pan”), the statistical ana-
lysis was performed only in results of P. falciparum test
line, due to the small number of infections expected by
parasites other than P. falciparum.
The prevalence of malaria among febrile patients pre-
senting to a health clinic in the study area was estimated
to be 10 to 15%, with greater than 95% of malaria cases
caused by P. falciparum.
Based on this prevalence of P. falciparum infection in
the study area, the sample size was estimated to be be-
tween 1,200 to 1,500 subjects, under the assumption that
it would provide approximately 120-225 positive results
for P. falciparum. Assuming that the sensitivity and spe-
cificity of the interpretation of SD RDT is the same as
the sensitivity and specificity of the human-eye interpret-
ation this sample size would provide 95% confidence in-
tervals within 5% of the point estimate.
Results
Between January and March 2012, a total of 1,482 subjects
were screened. Of the total, 1,346 (90.8%) met inclusion
criteria after the pilot period and were included in the
study and final analysis (Figure 2). The main demographic
features of the cohort are described in Table 1. The pro-
portion of female participants was 60.3%, and the popula-
tion was predominantly children and young adolescents
below the age of 17 years (64.1%) (Table 1). The prevalence
of microscopically confirmed malaria was 11.1% for the full
cohort, and varied among the four sites: 3.4% at Bagamoyo
District Hospital, 11.9% at Yombo dispensary, 12.2% at
Kiwangwa dispensary, and 15.6% at Fukayosi dispensary.
Performance characteristics of the Deki Reader and visual
interpretation of SD RDTs to gold standard
When compared to standard TBS microscopy, results in
interpretation of SD RDT, the Deki Reader™, had a sen-
sitivity of 95.3% (95% CI, 90.6-97.7) and a specificity of
94.6% (95% CI, 93.5-96.1). The sensitivity of expert vis-
ual interpretation of RDTs was 94.7% (95% CI, 89.8-
97.3) and the specificity was 95.6% (95% CI, 94.2-96.6)
(Table 2).
Figure 2 Patient Flowchart for Deki Reader RDT result. *Subjects were enrolled as part of a pilot run of the study, but excluded from the final
analysis as planned. Intent-to-Assay: Included all enrolled subjects who met all inclusion and exclusion requirements and whose test was inserted
within the 30-minute window, as per protocol.
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Reader to visual interpretation of SD RDTs
The percentage agreement for the interpretation of
RDTs between the device and visual was 98.7% (95% CI,
93.4-98.6) when a negative result was obtained, 96.9%
(95% CI, 97.8-99.2) when a positive result was obtained,
and an overall percentage agreement of 98.4% (95% CI,











≥ 1 to < 5 410 (30.5%)
≥ 5 to <17 430 (31.9%)
≥ 17 to <65 460 (34.2%)
≥ 65 35 (2.6%)difference in the sensitivity (0.7, 95% CI, -2.7-4.2), nor in
the specificity (-0.7, 95% CI, -1.5-0.1) between the two
methods of interpretation.
Discordant test results between Deki Reader and visual
interpretation of SD RDTs
There were 29/1,346 (2.2%) discordant test results be-
tween the Deki Reader and the visual interpretation of
RDTs. In eight of these cases, the software did not detect
a control line, and therefore classified the test as “in-
valid” according to manufacturer’s recommendations.
The visual interpretation of these eight cases was “nega-
tive” in six of them and “positive” in two. No re-testing
of these samples was done. Out of the remaining 21
cases, in 15 the visual interpretation was reported as
“negative”, and the device interpretation was “positive”;
while in the other six cases, it was the other way around.
In 10 (48%) of these 21 cases the discrepancy seems to
have originated in a clerical error when entering the in-
formation into the device. Analysis of RDT images for
these 10 cases that were transmitted to the portal and
sorted in the database showed either the presence of a
clearly visible control and test line(s) (and human expert
interpretation was erroneously entered as “negative”) or
a complete absence of test lines in the diagnostic strip
(and human expert interpretation was erroneously en-
tered as “positive”). The remaining 11 discrepant cases
Table 2 Deki Reader and Visual diagnostic performance using microscopy as “gold standard”
N Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Overall diagnostic accuracy (95% CI
Deki reader 1346 95.3 (90.6, 97.7) 94.9 (93.5, 96.1) 70.3 (63.7, 76.2) 99.4 (98.7, 99.7) 95 (93.7, 96.0)
Visual 1346 94.7 (89.8, 97.3) 95.6 (94.2, 96.6) 72.8 (66.2, 78.6) 99.3 (98.6, 99.6) 95.5 (94.2, 96.5)
Comparison 0.7 (-2.7, 4.2) -0.7 (-1.5, 0.1)
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in which the intensity of the test line was around the
cut-off of the software, in some cases producing very
faint lines that could have been missed by visual inspec-
tion (see Additional file 1). The PCR test results in these
11 cases showed two samples positive for P. falciparum,
one of which was also positive by microscopy. Therefore,
in 9/1,336 cases (0.7%) discrepant results were truly false
positive results.
Feasibility outcomes
The present field study confirmed that the Deki Reader,
operated by laboratory technicians after a two-day train-
ing session, is able to collect information related to diag-
nostic events using malaria RDTs. The information
collected, along with the correspondent RDT image, was
sent immediately from remote areas to a database, being
part of the Fio cloud services with 100% fidelity. Study
managers were able to monitor the progress of the study
at each of the participating sites by using the Fio portal
to review upcoming data in real time. Access to the data
was possible from different locations and permanent.
TBS microscopy quality control
The overall agreement between TBS microscopy and
PCR results was 88.9% (48/54). In three samples each of
TBS positive and TBS negative results, PCR results were
discordant (Table 4). Results of PCR were concordant in
87% (20/23) of TBS microscopy positive results, and in
90% (28/31) of TBS microscopy negative results.Discussion
Strengthening of malaria control programmes and large
investments in malaria prevention in SSA has resulted in
significant accomplishments in the reduction of both
malaria mortality and morbidity. In turn, decreasing
malaria transmission has led to a decline in the propor-
tion of fevers attributable to malaria. This fact, and the
use of relatively expensive artemisinin-containing treat-
ments as first-line anti-malarials have made it veryTable 3 Comparison of performance between Deki







98.7 (97.8, 99.2) 96.9 (93.4, 98.6) 98.4 (97.6, 99)important to provide accurate malaria diagnosis at all
levels of health systems [10,16]. The WHO now recom-
mends parasitologic confirmation in all clinically
suspected cases prior to treatment [1].
Diagnosis at POC can be done by means of malaria
RDTs, since they represent an accurate, affordable, rela-
tively easy-to-use malaria diagnostic method, and in some
instances have been reported to be even more reliable
than microscopy to provide widespread access to diagnosis
[17-19]. In order to be widely adopted, malaria RDTs must
have both high (>95%) sensitivity and specificity in field
settings. High sensitivity is necessary to ensure that true
cases of malaria are identified and appropriately managed
while high specificity is needed to avoid false positive re-
sults that would lead to missed diagnosis of the true cause
of fever, but also to avoid unnecessary anti-malarial treat-
ment. Implementation of RDT programmes at large scale
is promoted by WHO [10] as part of the T3 initiative in
highly endemic countries [20]. Despite their simplicity and
apparent ease of processing and interpretation, there have
been reports of considerable deficiencies in the processing
and interpretation of RDTs in general, and malaria RDTs
in particular [8,9,15], which indicates the need for a robust
QA plan to be implemented along with RDT-based diag-
nostic programmes. A recent publication on QA strategy
in rural Tanzania, based on current WHO recommenda-
tions, concluded that “Future research in RDT implemen-
tation should focus on testing QA strategies that are less
labour intensive, costly, and more widely implementable.
The WHO recommendation to obtain blood smears with
20 positive and 20 negative RDTs should be tested in a
variety of transmission settings and other QA strategies
employing positive controls, PCR, or other diagnostic
methods should be explored to ensure reliable perform-
ance of RDTs in field conditions” [12].
On the other hand, over the last decade considerable
effort has been dedicated to the development of auto-
mated RDT readers, utilizing diverse technologies such
as digital image software analysis, and scanning software.
The idea behind the use of automated readers is to
minimize human error involved in processing and inter-
pretation of RDTs, which can be considerable, as indi-
cated above [8,9,15]. As a result, a number of devices
have been introduced in the market place. However,
most of them are still relatively expensive and not suit-
able for operation at POC conditions such as those in
malaria-endemic regions of rural Africa [21].
Table 4 Two by two table of microscopy and PCR results
PCR
Positive Negative Total
Microscopy Positive 20 3 23
Negative 3 28 31
Total 23 31 54
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standard to assess the performance characteristics of
Deki Reader, an automated RDT reader that uses digital
software image analysis technology, in the interpretation
of malaria SD RDTs. The performance characteristics of
Deki Reader were also compared to that of visual inter-
pretation of the SD RDTs performed by experienced la-
boratory technicians. The main findings are that the
sensitivity and specificity of Deki Reader in the interpret-
ation of SD RDTs were 95.3% and 94.6% respectively,
while those of visual interpretation by experts were
94.7% and 95.6% respectively (Table 2). There was no
statistically significant difference between the diagnostic
accuracy of the Deki Reader and the visual interpretation
of malaria RDTs.
Based on these results, the present study has demon-
strated that RDT interpretation by Deki Reader is sub-
stantially equivalent to that of visual interpretation as
performed by laboratory technicians with vast experi-
ence in RDT processing and interpretation. The fact that
the results from the current study, conducted in rural
health facilities and in actual clinical practice by enrol-
ling patients who were receiving routine care for mal-
aria, suggest that a device like the Deki Reader can be
used in routine care for interpretation of RDT and there-
fore provide health care workers at different levels of the
health care system, from community health workers to
laboratory technicians to clinicians, with high-quality
diagnostic results at POC. This feature will enable health
care workers to make informed clinical judgments, while
at the same time collecting and reporting pivotal demo-
graphic, clinical and programmatic information to health
programme administrators in a central location.
The information collected during the present study was
automatically encrypted, and transmitted in real time
using local mobile network providers into a secured cloud
database. The principal investigator and research study co-
ordinator were able to access the information permanently
using a specific password to log in to the web portal sys-
tem. This way they were able to monitor field activities in
each of the four participating centres, and to perform
quality control activities in the processing of RDTs by
conducting routine examination of the images coming
from the study centres.
The results showed a relatively small percentage (2.2%)
of discordant results between Deki Reader and visualinterpretation in this study. A closer look at the discordant
results showed that in about half the cases, the discrep-
ancy was due to apparent clerical mistakes suggesting that
device interpretation was correct; while in only nine cases
(0.7%) was this due to a false positive result interpretation
by the device (see Additional file 1). The importance of
this finding is negligible considering that the criterion
established by WHO for procurement of malaria RDTs is
of less than 10% of false positive rate [6]. Nonetheless, the
newest version of the software in the device has been im-
proved and is now able to capture some of the more com-
mon causes of smearing of the diagnostic strip in the
RDTs that can lead to automated interpretation of false
positive results, as in some of the cases shown here. In all
instances the user will be requested to repeat the test and
to adhere to the manufacturer recommendations related
for processing of the mRDT.
The availability of a system such as the one tested in the
present study can bring significant benefits to the wide-
spread implementation of malaria RDTs being adopted by
many countries in SSA. At the POC level, the increased ac-
curacy in diagnosis delivered by automated interpretation
of RDTs could increase adherence to national treatment
guidelines, decreasing the rates of overtreatment of non-
malaria cases. The beneficial effects here may extend well
beyond malaria, as the Deki Reader is a universal RDT
reader. That means it can interpret not only multiple
brands of malaria RDTs, but also RDTs for other infectious
diseases such as HIV, syphilis, dengue fever, and others.
The expedited flow of accurate information the system
brings from peripheral dispensaries and health centres to
central locations where decision-making health programme
administrators are located is expected to deliver great bene-
fits in terms of quality control of diagnostic tests and case
management, assessment of overall efficiency of the health
care system and inventory management.
Limitations
One of the main limitations of the present study was to
use TBS microscopy as the gold standard method. It is
well known that microscopy is an imperfect subjective
diagnostic method with multiple factors affecting inter-
pretation of blood smears, such as variability in techniques
of blood film preparation, staining, reading standards, and
most importantly high dependency on the level of expert-
ise of the examining microscopists [17,22-26]. Therefore,
to limit these difficulties, microscopy in this study was
performed by experienced technicians in a single referral
centre who analysed films independently and were blinded
to the RDT results.
Another limitation is in the generalization of the results
of the present study since only one malaria RDT (SD
Bioline Malaria Antigen Pf/Pan) was tested to assess the per-
formance characteristics of the Deki Reader. Considering
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sults cannot be generalize to other RDTs. However, the
function of the Deki Reader is to interpret the presence or
absence of a test line signal, independent of the analytes
that are finally deposited on it. Hence, the performance of
the automated reader is independent of the underlying im-
munochemistry and thus should provide similar perform-
ance characteristics for other malaria RDTs using different
antigens and for RDTs used in diagnosis of other diseases
in general.
Conclusions
Despite the limitations of this study, the results obtained
reflect the real situation of performance characteristics of
the Deki Reader on interpreting malaria RDTs. More stud-
ies are recommended to provide further evidence of
current findings and on the performance of the device
using other types of RDTs. Further studies looking at feasi-
bility of the use of the Fio system at community health
worker level, cost benefit, suitability and acceptability by
users, as well as involving RDTs for other diseases and
other brands of malaria RDTs are warranted.
Additional file
Additional file 1: Discordant test Results between Deki Reader and
Visual Interpretation of RDTs.
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